Priapism is a condition first described by Tripe in 1845. It has been defined as a pathological condition of penile erection that persists beyond or is unrelated to sexual stimulation. Two variants of priapism have been well described. The ischemic priapism (also known as low-flow priapism) and nonischemic priapism (or high flow priapism) have unique and distinct causes. It is important to distinguish these two conditions as the treatment for each is different. This review will focus on the two types of priapism and the appropriate diagnostic work-up for each. As well, the medical and surgical treatment options for these two conditions will be described in detail. A third entity known as stuttering priapism will also be discussed as will its unique treatment alternatives.
Introduction
Priapism has been defined as a pathological condition where a penile erection persists beyond or is unrelated to sexual stimulation. Priapism may be classified as ischemic or nonischemic. In the past, terms such as low-flow/high-flow priapism have been used. In fact, these terms are misleading because with low-flow priapism, there is essentially no flow into or out of the corpora cavernosa. We will therefore strictly use the terms ischemic and nonischemic priapism.
The diagnosis of priapism should occur as soon as possible. The diagnosis and classification of priapism may be based on history and physical exam, or after corporal blood aspiration. Acidotic (pHo7.25, pO 2 o30, pCO 2 460) blood aspirated from the penis indicates an ischemic priapism. To further elucidate the type of priapism, duplex Doppler ultrasound may be performed. With ultrasonography, no cavernosal arterial flow is seen in ischemic priapism, while a ruptured cavernosal artery with unregulated arterial blood flow and blood pooling may be seen in the nonischemic type of priapism. Prior to any form of treatment, informed consent is crucial as upwards of 50% of patients will have some form of erectile dysfunction regardless of the treatment approach.
Nonsurgical treatment of ischemic priapism
In general, treatment is aimed at the primary cause of the priapism if it can be identified. The goal of treatment is to relieve pain and abort the erection that may cause damage to the corpora. The treatment is applied in a stepwise pattern with increasing invasiveness balanced against prolonged ischemia, fibrosis, and impotence if treatment is delayed.
The first line of treatment includes evacuation of old blood from the corpora cavernosa via a 19-or 21-guage butterfly (scalp vein) needle. Aspiration of old blood is usually difficult; we find the 'milking' method to be more successful. The next step is the injection of a diluted alpha-adrenergic agonist solution into the corporal space. Some use irrigation but we prefer injection so that the amount of the alpha adrenergic agent can be delivered precisely. Epinephrine, norepinephrine, norepinephrine with xylocaine, and phenylephrine have all been used with success. Our medication of choice is phenylephrine, which is a pure alpha-1 adrenergic agonist with minimal cardiac side effects. Old blood is aspirated or 'milked' out of the corpora until fresh blood is seen in the syringe. Phenylephrine at 500 mg (250 mg in patients with cardiovascular disease) is injected via the same butterfly needle and the penis is observed for 3-5 min. If the penis is rigid again, we will aspirate 10 ml more of blood and inject another 500 mg of diluted phenylephrine. This procedure is repeated every 3-5 min until detumescence occurs. The phenylephrine solution is made by mixing 10 mg/ml of phenylephrine with 19 ml of normal saline.
Complications of treatment can occur if phenylephrine soultion is given too much and too fast. Early complications include headache, acute hypertension, bradycardia, palpitations, sweating, and arrhythmias. In patients with cardiovascular disease, we recommend monitoring of blood pressure and heart rate during the course of treatment.
Surgical treatment of ischemic priapism
If medical management is unsuccessful in achieving detumescence, a surgical approach is then necessary. The goal of surgery is to allow blood to flow in and out of the corpora cavernosa again by creating a new route for venous return as well as to avoid the potential of erectile tissue death, fibrosis, and subsequent impotence.
Principles of priapism surgery
The basis of priapism surgery involves creating a fistula between the corpus cavernosum and the glans penis, the corpus spongiosum, the deep dorsal vein, or the saphenous vein. Ideally, the penis should be completely flaccid after the shunting procedure. However, in cases of priapism over 48 h duration, a partial erection often remains after shunting. In this situation, we found monitoring of intracavernous pressure to be helpful. The arterial line set up should be connected via a 21-gauge scalp vein needle inserted directly into the corpus cavernosum ( Figure 1 ). An intracavernous pressure of less than 40 mmHg or less for 10 min after establishment of the fistula (or after closure of skin in cases of glans-cavernosal shunt) indicates a successful procedure. If the pressure is over 40 mmHg, a larger shunt is needed.
Glans-cavernosal shunt. a. Winter Shunt. This is the least invasive surgical procedure for priapism. Under local anesthesia, a Trucut biopsy needle is inserted through the glans into the corpus cavernosum. A core of tunica albuginea separating the glans and the corpus cavernosum is removed by the needle, thus creating a fistula. Several passes are necessary on each side in order to create enough communicating channels to achieve a successful outcome.
b. Ebbehoj procedure. In this procedure, a #15 blade scalpel is inserted through the glans into the corpus cavernosum. The scapel is turned 901 away from the meatus and pulled back to create an opening in the tunica albuginea which separates the glans and the corpus cavernosum. 1 The overlying glans is then closed using chromic suture. Swelling of the glans and detumescence suggest a positive result of the surgery. Again, several fistulae may need to be created to achieve the best result ( Figure 1 ). We prefer a #10 blade scalpel inserted vertically through the glans into the corpus cavernosum, turns 901 laterally and then pulls out to create a large 'T'-shaped opening in the tunica The blade is inserted into each corpus cavernosum from the glans, turns 901 laterally then pulls out to create a T-shaped shunt.
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c. Al-Ghorab shunt. This shunt is better performed under general anesthesia. A 2 cm transverse incision is made on the dorsum of the penis 1 cm distal to the coronal ridge. The bulging corporal bodies are exposed and grasped with a Kocher clamp; a 5 mm segment of tunica albuginea is then excised from the tips of the bodies. 2 Dark blood usually drains from the corporal bodies. When detumescence occurs, the skin is reapproximated using chromic sutures so as not to obliterate the spongy vascular space of the glans penis. We prefer two separate vertical incisions because a transverse incision may cut the sensory nerves to the dorsal aspect of the glans.
Cavernoso-spongiosal shunt (Quackles). The patient is anesthetized and placed in the lithotomy position. A longitudinal incision is made in the perineum. The bulbo-cavernous muscle is dissected off the corpus spongiosum. A foley catheter may be placed to aid in the identification and dissection of the urethra. A longitudinal incision is made in the spongiosal and cavernosal bodies close enough to each other, such that the two openings may be sewn together. Some investigators recommend excising a 1-cm long ellipse of tissue rather than just a simple incision to create a better fistula. 3 After the corpus cavernosal body has been opened, it is important to irrigate the stagnant blood from the penis until the return is bright red. The walls of the fistula can then be sutured together using a 5-0 PDS suture (Figure 3) . A unilateral shunting procedure is sufficient as long as the intracavernosal pressure remains less than 40 mmHg after 10-15 min. If the pressures are higher, a shunt on the opposite side is recommended.
Cavernoso-saphenous vein shunt (Grayhack) . The patient is placed supine with legs in the frog-leg position. The first incision is made at the saphenofemoral junction which is approximately 3-4 cm below the inguinal ligament and extended distally in the line along the saphenous vein. The vein is identified and mobilized for a distance of approximately 8-10 cm distal to the fossa ovalis. Additional length of the vein may be mobilized if tension is created by tunneling the vein subcutaneously to the root of the penis. After the distal margin of the vein is ligated, a second incision is made on the lateral margin of the shaft at the root of the penis. Dissection is carried down to the tunica albuginea. A tunnel is created between the two incisions. An ellipse of tunica albuginea 1.5 Â 0.5 cm is excised. The corporal body is milked until the stagnant blood is evacuated. The saphenous vein is passed through the subcutaneous tunnel without tension or torsion, then spatulated and anastomosed to the tunica albuginea using a continuous 5-0 PDS suture 4 ( Figure 4 ).
Cavernoso-dorsal vein shunt (Barry) . In a Barry shunt, 5 a 4 cm skin incision is made at the base of the penis. The superficial or deep dorsal vein is identified and mobilized. It is ligated distally and divided. The proximal limb is spatulated on its ventral surface and anastomosed to the corpus cavernosum in a tension-free manner ( Figure 5 ). In theory, this shunt should be very effective Figure 3 Cavernoso-spongiosal shunt (Quackels) . It is important that the shunt is created in the perineum between the urethral bulb and crura. If placed too distal, it will not be effective and will carry a higher risk of urethral injury. Figure 4 Cavernoso-saphenous vein shunt (Grayhack) . The saphenous vein is mobilized by dividing and ligating the tributaries. It is crucial that the saphenous vein is passed without tension, torsion, or angulation.
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because the dorsal penile veins are not involved in priapism and it bypasses any distal penile edema or thrombosis. However, in practice, perhaps due to the size of the vein, it has not been as successful as expected.
Postoperative care
In the immediate postoperative period, the penis may appear partially erect due to edema and postischemic hyperemia. If any doubt exists, penile ultrasound or cavernosal blood gas sampling may be performed. Circular or compressive dressings must be avoided and occasional manual milking and squeezing of the penis will ensure the shunt remains patent and the priapism does not recur. Urethral catheters should be removed as soon as possible and avoided altogether in a cavernoso-spongiosal shunt. Perioperative antibiotics should be given to all patients with ischemic priapism.
Treatment of nonischemic priapism
A history of perineal trauma and a nonpainful continuous or intermittent erection strongly suggests a nonischemic priapism. This is often due to a ruptured cavernous arterial branch within the corpus cavernosum. If cavernosal blood gases are performed, they will most likely reflect arterial levels. Color duplex ultrasound is helpful in localizing the high flow and the site of rupture.
It is important to note that these patients can be safely followed conservatively for several months with the hope that the fistula will spontaneously close. In the early stages, ice or pressure packing may cause sufficient vasospasm and thrombosis of the ruptured artery to effect closure of the fistula. However, in most cases, closure does not spontaneously occur and selective angiographic embolization of the ruptured artery may be needed. Embolization may be done using one or a combination of gelfoam, metallic coils, or autologous clot. In the unlikely scenario that the angiographic attempt fails, a repeat embolization may be done or open surgical ligation of the ruptured artery may be attempted. This is performed with intraoperative Doppler ultrasound to aid in localization of the ruptured artery.
Recurrent (stuttering) priapism
Stuttering or recurrent priapism can occur in patients with sickle cell trait or disease. It can also be seen in nonsickle cell patients with prior episodes of priapism. Recurrent priapism has also been described in patients with nonischemic priapism. The exact mechanism resulting in stuttering priapism is unknown, however, some hypothesize that there is an alteration of adrenoreceptors or a scarring of intracavernous venules that may cause the recurrent episodes.
Various therapies have been used to treat stuttering priapism, including automated red cell exchanges for patients with sickle cell anemia 6 or oral alpha adrenergic medications (Etilefrin). 7 Other options for treatment include self-intracavernosal injection of an alpha adrenergic agent such as phenylephrine. 8 If the patients have no concerns regarding decreased libido and the priapism epi- 
Stuttering priapism
When and how to treatFtreat as ischemic priapism with diluted phenylephrine How to preventFantiandrogen, GnRH agonist, or baclofen Figure 5 Cavernoso-dorsal vein shunt (Barry) . The dorsal vein is sutured to a window in the corpus cavernosum to provide shunting.
Treatment of priapism DJ Bochinski et al sodes continue, an anti-androgen or gonadotropinreleasing hormone agonist may be used for 6 months and readministered if necessary. These agents suppress nocturnal penile erection and can prevent recurrent episodes of priapism. 9 In a recent report, balclofen 40 mg taken at bed time was successful in preventing recurrent priapism for up to 1 year. 10 
Conclusion
Better understanding of penile physiology, pathophysiology and pharmacology has dramatically improved our understanding and management of priapism. Ischemic priapism is a compartment syndrome and urgent management is required to prevent erectile tissue death, fibrosis, and impotence. On the other hand, in nonischemic priapism, the erectile tissue is perfused with well-oxygenated blood and conservative treatment for several weeks to months is recommended. For stuttering priapism, successful preventive treatments are now available. These include antiandrogens, gonadotropin releasing hormone agonists, and baclofen (Table 1) .
